Deal of the Day — limited-time pharmacy picks!
Ribasure 200mg Capsule

Ribasure 200mg Capsule

Prescription requiredRx Required

Salt Composition: Ribavirin 200mg

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

140 Capsule

About The Product

Hepatitis C

Ribasure 200mg Capsules are antiviral drugs. Chronic infections caused by the Hepatitis C virus (HCV) are treated with it.

Ribasure 200mg eliminates the infection by stopping viruses from multiplying in human cells.

Uses

Treatment of Chronic hepatitis C virus (HCV) infection

Side Effects

Most side effects of Ribasure 200mg Capsule do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

  • Cough and vomit
  • Upset stomach or constipation 
  • Diarrhea  
  • Heartburn  
  • Loss of appetite 
  • Weight loss 
  • Dry mouth  
  • Memory loss
  • Dry or itchy skin
  • Sweating
  • Irregular or painful menstruation
  • Muscle pain
  • Hair loss
  • Blood in stools

How To Use

  • ​Take the Ribasure 200mg capsule exactly as your healthcare provider prescribes.
  • Do not chew, crush, or break the capsule.

How It Works

Ribavirin is a synthetic nucleoside analog that shows in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin exerts its effects against HCV is not known. HCV RNA levels decline in a biphasic manner in responding patients with hepatitis C who have received treatment with 180 µg peginterferon alfa-2a.

The first phase of decline occurs 24 to 36 hours after the first dose of peginterferon alfa-2a and is followed by the second phase of decline, which continues over the next 4 to 16 weeks in patients who gain a sustained response.

Ribavirin showed no significant effect on the initial viral kinetics over the first 4 to 6 weeks in patients treated with the combination of Ribavirin and pegylated interferon alfa-2a or interferon alfa.

Safety Advice

Alcohol

It is advisable not to consume alcohol while taking this medicine.

Pregnancy

Do not take Ribasure capsule without consulting the doctor, in case of pregnancy.

Breast Feeding

Without a doctor's consultation, do not take this medicine if you're breastfeeding.

Driving

It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.

Kidney

Do not take Ribasure 200mg capsule without a doctor's consultation in case of kidney problems.

Liver

Share your medical history with the doctor in case of liver disease before taking this medicine.

Missed Doses

  • If you miss any dose, consult your doctor.
  • Do not take twice the dose to catch up on the missed one.
  • This will cause severe side effects and impact your overall health and duration of treatment.

FAQs

​ Ribasure Capsule is an antiviral medicine used in the treatment of chronic hepatitis C.

​

Reference

Final analyses from the ADHERE registry: Enhanced adherence to HCV therapy with higher dose ribavirin formulation (RibaPak vs RBV). (2010).

Journal of Hepatology, 45(12), 358-500 Medthority. (n.d.).

Ribavirin 200 mg capsules – Drug information, pharmacokinetics, and clinical uses. Retrieved August 14, 2025, from https://www.medthority.com/drugs/j-antiinfectives-for-systemic-use/j05/j05a/j05ap/j05ap01/ribavirin-200mg-capsules/ National Center for Biotechnology Information.

(2025). Bioequivalence studies of ribavirin formulations.

PubMed Central. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126353/ Preston, S.

L., Drusano, G. L., Glue, P., Nash, J., Gupta, S.

K., & McNamara, P. (1999).

Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology. Antimicrobial Agents and Chemotherapy, 43(10), 2451–2456.

Sandoz. (2021).

A relative bioavailability study of Ribavirin 200 mg capsules (Geneva Pharmaceutical) versus Rebetol 200 mg capsules (Schering). ClinicalTrials.gov Schering‑Plough.

(2025). A single-dose, two-way crossover study of the bioequivalence of ribavirin formulation (solution vs capsule).

ToetsingOnline. Shah, S.

N., & Shahzad, W. (2015).

Manufacturing of a new formulation of ribavirin 200MG capsules. Canadian Journal of Applied Sciences, 5(2), 15–20.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026